Association Between Globulin and Diabetic Nephropathy in Type2 Diabetes Mellitus Patients: A Cross-Sectional Study.
Wang J, Liu F, Kong R, Han X.
Front Endocrinol (Lausanne). 2022 Jul 8;13:890273. doi: 10.3389/fendo.2022.890273. eCollection 2022.
PMID:35898464
Combine and Conquer: With Type 2 Diabetes Polypharmacy Is Essential Not Only to Achieve Glycemic Control but Also to Treat the Comorbidities and Stabilize or Slow the Advancement of Diabetic Nephropathy.
Bell DSH.
J Diabetes Res. 2022 Aug 4;2022:7787732. doi: 10.1155/2022/7787732. eCollection 2022.
PMID:35967126
miR-21-3p and miR-192-5p in patients with type 2 diabetic nephropathy.
Akpınar K, Aslan D, Fenkçi SM, Caner V.
Diagnosis (Berl). 2022 Aug 18;9(4):499-507. doi: 10.1515/dx-2022-0036. eCollection 2022 Nov 1.
PMID:35976169
Direct medical cost of nephropathy in patients with type 2 diabetes.
Gülümsek E, Keşkek ŞÖ.
Int Urol Nephrol. 2022 Jun;54(6):1383-1389. doi: 10.1007/s11255-021-03012-4. Epub 2021 Oct 18.
PMID:34661824
Association of adiponectin polymorphisms with the risk of diabetic nephropathy in type 2 diabetes: a meta-analysis.